Amare Pratibha Kadam, Baisane Chanda, Nair Reena, Menon Hari, Banavali Shripad, Kabre Sharayu, Gujral Sumit, Subramaniam P
Cancer Cytogenetics Laboratory, Tata Memorial Hospital, Mumbai, India.
Indian J Hum Genet. 2011 May;17(2):54-8. doi: 10.4103/0971-6866.86174.
Acute promyelocytic leukemia (APL) is characterized by a reciprocal translocation t(15;17)(q22;q21) leading to the disruption of Promyelocytic leukemia (PML) and Retionic Acid Receptor Alpha (RARA) followed by reciprocal PML-RARA fusion in 90% of the cases. Fluorescence in situ hybridization (FISH) has overcome the hurdles of unavailability of abnormal and/or lack of metaphase cells, and detection of cryptic, submicroscopic rearrangements. In the present study, besides diagnostic approach we sought to analyze these cases for identification and characterization of cryptic rearrangements, deletion variants and unknown RARA translocation variants by application of D-FISH and RARA break-apart probe strategy on interphase and metaphase cells in a large series of 200 cases of APL. Forty cases (20%) had atypical PML-RARA and/or RARA variants. D-FISH with PML/RARA probe helped identification of RARA insertion to PML. By application of D-FISH on metaphase cells, we documented that translocation of 15 to 17 leads to 17q deletion which results in loss of reciprocal fusion and/or residual RARA on der(17). Among the complex variants of t(15;17), PML-RARA fusion followed by residual RARA insertion closed to PML-RARA on der(15) was unique and unusual. FISH with break-apart RARA probe on metaphase cells was found to be a very efficient strategy to detect unknown RARA variant translocations like t(11;17)(q23;q21), t(11;17)(q13;q21) and t(2;17)(p21;q21). These findings proved that D-FISH and break-apart probe strategy has potential to detect primary as well as secondary additional aberrations of PML, RARA and other additional loci. The long-term clinical follow-up is essential to evaluate the clinical importance of these findings.
急性早幼粒细胞白血病(APL)的特征是15号和17号染色体发生相互易位t(15;17)(q22;q21),导致早幼粒细胞白血病(PML)和维甲酸受体α(RARA)基因中断,90%的病例随后会出现相互的PML-RARA融合。荧光原位杂交(FISH)克服了异常细胞或中期细胞不可用以及隐匿性、亚微观重排检测困难的障碍。在本研究中,除了诊断方法外,我们试图通过对200例APL病例的间期和中期细胞应用双融合FISH(D-FISH)和RARA断裂分离探针策略,分析这些病例以鉴定和表征隐匿性重排、缺失变异体和未知的RARA易位变异体。40例(20%)有非典型PML-RARA和/或RARA变异体。使用PML/RARA探针的D-FISH有助于鉴定RARA插入到PML。通过对中期细胞应用D-FISH,我们记录到15号染色体易位到17号染色体会导致17q缺失,这会导致相互融合缺失和/或der(17)上残留RARA。在t(15;17)的复杂变异体中,PML-RARA融合后,残留RARA插入到der(15)上靠近PML-RARA的位置是独特且不寻常的。在中期细胞上使用RARA断裂分离探针进行FISH被发现是检测未知RARA变异易位如t(11;17)(q23;q21)、t(11;17)(q13;q21)和t(2;17)(p21;q21)的非常有效的策略。这些发现证明,D-FISH和断裂分离探针策略有潜力检测PML、RARA和其他额外位点的原发性以及继发性额外畸变。长期临床随访对于评估这些发现的临床重要性至关重要。